Earnings History Data for ADC Therapeutics SA (ADCT) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

ADC Therapeutics SA

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-03-2024	PM		ADCT	ADC Therapeutics SA	358.86	-1.03	-0.40	-0.30	ADC Therapeutics Non-GAAP EPS of -$0.97, revenue of $16.79M beats by $1.53M [3/13/2024 7:04 AM]	3.86	-0.59 (-13.26%)	4.35	-0.10 (-2.25%)	0.36 - 6.04	1,647,800	560,000	16,870
ADC Therapeutics Q4 Earnings Preview [3/12/2024 10:52 AM] ADC Therapeutics Non-GAAP EPS of -$0.97, revenue of $16.79M beats by $1.53M [3/13/2024 7:04 AM]
07-11-2023	PM		ADCT	ADC Therapeutics SA	64.51	-0.58	-0.61	-0.65	ADC Therapeutics Non-GAAP EPS of -$0.41, revenue of $14.49M misses by $0.67M [11/7/2023 7:15 AM]	0.73	-0.13 (-15.41%)	0.83	-0.03 (-3.82%)	0.63 - 5.75	404,149	280,000	9,293
ADC Therapeutics Non-GAAP EPS of -$0.41, revenue of $14.49M misses by $0.67M [11/7/2023 7:15 AM] ADC Therapeutics receives NYSE notice of non-compliance with continued listing standards [11/7/2023 11:08 AM]
08-08-2023	PM		ADCT	ADC Therapeutics SA	118.54	-0.58	-0.44	-0.84	ADC Therapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $19.2M misses by $22.37M [8/8/2023 7:28 AM]	1.61	0.18 (12.59%)	1.50	0.07 (4.90%)	1.22 - 10.82	692,190	470,000	10,269
ADC Therapeutics GAAP EPS of -$0.58 misses by $0.01, revenue of $19.2M misses by $22.37M [8/8/2023 7:28 AM]
09-05-2023	PM	7:00 AM ET (May 9)	ADCT	ADC Therapeutics SA	158.06	-0.74	-0.80	-0.22	ADC Therapeutics Non-GAAP EPS of -$0.53, revenue of $18.99M misses by $1.1M [5/9/2023 7:10 AM]	2.19	0.07 (3.30%)	0.0	0.0 (0.00%)	1.85 - 10.98	338,269	350,000	0
ADC Therapeutics Non-GAAP EPS of -$0.53, revenue of $18.99M misses by $1.1M [5/9/2023 7:10 AM]
28-02-2023	PM	7:00 AM ET (Feb 28)	ADCT	ADC Therapeutics SA	334.67	-0.30	-0.49	-0.45	ADC Therapeutics Non-GAAP EPS of -$0.10 misses by $0.05, revenue of $19.8M misses by $45.69M [2/28/2023 7:02 AM]	3.62	-0.45 (-11.06%)	3.98	-0.09 (-2.21%)	2.69 - 17.28	444,723	300,000	26,293
ADC Therapeutics Non-GAAP EPS of -$0.10 misses by $0.05, revenue of $19.8M misses by $45.69M [2/28/2023 7:02 AM]
08-11-2022	PM	7:00 AM ET (Nov 8)	ADCT	ADC Therapeutics SA	339.31	-0.65	-0.51	-0.93	ADC Therapeutics Non-GAAP EPS of $0.13, revenue of $76.32M [11/8/2022 7:11 AM]	4.16	-0.10 (-2.35%)	4.60	0.34 (7.98%)	4.00 - 29.74	443,688	340,000	22,666
ADC Therapeutics Non-GAAP EPS of $0.13, revenue of $76.32M [11/8/2022 7:11 AM] ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates [Nov-08-22 07:00AM] ADC Therapeutics to Participate in the Jefferies London Healthcare Conference [Nov-07-22 07:15AM]
09-08-2022	PM	7:00 AM ET (Aug 9)	ADCT	ADC Therapeutics SA	565.33	-0.84	-0.96	-0.95	ADC Therapeutics Non-GAAP EPS of -$0.73, revenue of $17.29M misses by $13.93M [8/9/2022 7:10 AM]	7.94	-0.11 (-1.37%)	8.05	0.0 (0.00%)	5.52 - 32.00	196,378	280,000	391
ADC Therapeutics Non-GAAP EPS of -$0.73, revenue of $17.29M misses by $13.93M [8/9/2022 7:10 AM]
09-05-2022	PM	7:00 AM ET (May 9)	ADCT	ADC Therapeutics SA	869.49	-0.22	-0.76	-0.67	ADC Therapeutics Non-GAAP EPS of -$0.36, revenue of $46.5M beats by $12.57M [5/9/2022 7:10 AM]	7.46	-3.49 (-31.87%)	10.95	0.0 (0.00%)	7.41 - 32.00	655,749	150,000	203
ADC Therapeutics Non-GAAP EPS of -$0.36, revenue of $46.5M beats by $12.57M [5/9/2022 7:10 AM] Should You Buy ADC Therapeutics (ADCT) Ahead of Earnings? [May-06-22 08:08AM] ADC Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Updates [May-09-22 07:00AM] ADC Therapeutics Announces CEO Transition [May-09-22 07:00AM] ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates [May-09-22 08:25AM]
03-03-2022	PM	7:00 AM ET (Mar 3)	ADCT	ADC Therapeutics SA	1,280	-0.45	-0.87	-0.73	ADC Therapeutics Non-GAAP EPS of -$0.39 beats by $0.49, revenue of $17.01M beats by $0.54M [3/3/2022 7:11 AM]	15.00	-1.22 (-7.52%)	17.03	0.81 (4.99%)	13.34 - 32.00	177,066	140,000	400
ADC Therapeutics Non-GAAP EPS of -$0.39 beats by $0.49, revenue of $17.01M beats by $0.54M [3/3/2022 7:11 AM] ADC Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates [Mar-03-22 07:00AM] ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates [Mar-03-22 08:25AM] ADC Therapeutics SA (ADCT) Q4 2021 Earnings Call Transcript [Mar-03-22 12:31PM]
02-11-2021	PM	7:00 AM ET (Nov 2)	ADCT	ADC Therapeutics SA	2,250	-0.93	-0.97	-0.29	ADC Therapeutics EPS misses by $0.01, beats on revenue [11/2/2021 7:14 AM]	29.18	-2.33 (-7.39%)	32.50	0.99 (3.14%)	20.01 - 38.34	774,913	160,000	1,140
ADC Therapeutics EPS misses by $0.01, beats on revenue [11/2/2021 7:14 AM] Is a Surprise Coming for ADC Therapeutics (ADCT) This Earnings Season? [Nov-01-21 08:38AM] ADC Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates [Nov-02-21 07:00AM] ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates [Nov-02-21 08:25AM]
03-08-2021	PM	7:00 AM ET (Aug 3)	ADCT	ADC Therapeutics SA	1,650	-0.95	-0.84	-0.71	ADC Therapeutics EPS misses by $0.09, beats on revenue [8/3/2021 7:08 AM]	22.72	2.01 (9.68%)	21.50	0.79 (3.81%)	20.01 - 53.35	395,333	220,000	141
ADC Therapeutics EPS misses by $0.09, beats on revenue [8/3/2021 7:08 AM] ADC Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates [Aug-03-21 07:00AM] ADC Therapeutics SA (ADCT) Reports Q2 Loss, Misses Revenue Estimates [Aug-03-21 08:45AM] ADC Therapeutics SA (ADCT) Q2 2021 Earnings Call Transcript [Aug-03-21 03:31PM]
06-05-2021	PM	7:00 AM ET (May 6)	ADCT	ADC Therapeutics SA	1,730	-0.67	1.00	0.00	ADC Therapeutics EPS beats by $0.17 [5/6/2021 7:04 AM]	22.61	0.61 (2.77%)	22.61	0.0 (0.00%)	21.16 - 56.59	417,185	540,000	3,038
ADC Therapeutics EPS beats by $0.17 [5/6/2021 7:04 AM] ADC Therapeutics ZYNLONTA (loncastuximab tesirine-lpyl) Added to National Comprehensive Cancer Network® Clinical Practice Guidelines in Oncology for B-cell Lymphomas [May-05-21 07:14PM] ADC Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Updates [May-06-21 07:00AM]
18-03-2021	PM	7:00 AM ET (Mar 18)	ADCT	ADC Therapeutics SA	1,920	-0.73	-0.68	0.00	ADC Therapeutics reports Q4 results [3/18/2021 7:09 AM]	28.99	-0.41 (-1.39%)	29.95	0.55 (1.87%)	21.51 - 56.59	572,910	510,000	4,166
ADC Therapeutics reports Q4 results [3/18/2021 7:09 AM] Loss-Making ADC Therapeutics SA (NYSE:ADCT) Expected To Breakeven In The Medium-Term [Mar-18-21 01:22AM] Adc Therapeutics SA to Host Earnings Call [Mar-18-21 06:30AM] ADC Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Business Updates [Mar-18-21 07:00AM] ADC Therapeutics SA (ADCT) Q4 2020 Earnings Call Transcript [Mar-18-21 01:30PM]
12-11-2020	PM	7:15 AM ET (Nov 12)	ADCT	ADC Therapeutics SA	2,510	-0.29	-0.77	0.00	ADC Therapeutics reports Q3 results [11/12/2020 7:11 AM]	34.00	-0.67 (-1.93%)	0.0	0.0 (0.00%)	25.10 - 56.59	143,002	155,723	0

18-08-2020	PM	Before the open (Aug 18)	ADCT	ADC Therapeutics SA	2,800	-0.71	-0.76	0.00		39.00	0.38 (0.98%)	0.0	0.0 (0.00%)	28.50 - 56.59	129,400	223,715	0